Editas Medicine

Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o
Biotech

Longtime Takeda R&D chief to depart next June—Chutes & Ladders

Longtime Takeda R&D chief to depart next June. Sofinnova lands Gilead alum as executive partner. Pyxis locks in interim CEO before phase 1 results.
CRISPR Therapeutics

Appeals court reignites row over CRISPR discovery

May 13, 2025 8:00am
A series of dice with a bag on them illustrating cost cuts

Editas lays off 65% after fruitless search for reni-cel partner

Dec 13, 2024 4:44am
An artists concept of gene editing A DNA strand appears in blue with edited regions in red

Editas prioritizes in vivo therapies, seeks reni-cel partner

Oct 22, 2024 9:39am
gene edits scientists gene editing CRISPR

Editas cashes in on Vertex Cas9 licensing agreement for $57M

Oct 4, 2024 5:06am
new hire welcome leadership people gap bridge

How Editas 'dragged' new CSO over after 37 years at Biogen

May 10, 2024 11:08am